Unlocking the Power of Health Data Through HIPAA Expert Determination
De-Identification as a Foundation for Responsible Innovation In a world where healthcare innovation depends on access to real-world data, safeguarding patient privacy isn’t just a legal obligation, it’s a cornerstone of trust. At Briya, we believe that privacy and progress can go hand in hand. That’s why we’re proud to share a major milestone in […]
5 AI & RWD Sessions at DIA Europe Not to Miss
As one of the largest conferences in the life sciences industry, DIA Europe is a must-attend event for both big and small pharma, academia, and healthtech. With a strong focus on regulatory policy, real-world evidence generation, and technological innovation, DIA’s agenda offers highly engaging and relevant sessions for its diverse audience. To help you make […]
Unlocking New Potential with Briya’s Dynamic Datasets
In the ever-evolving world of healthcare research, harnessing continuously updated, real-time, and comprehensive data isn’t just an advantage – it’s a transformative game-changer. Briya’s Dynamic Datasets are designed to meet the needs of 22nd-century researchers by offering unparalleled flexibility, scalability, and insights. What Are Dynamic Datasets? Unlike traditional static datasets, which are constrained to predefined […]
5 Real-World Data Predictions for 2025
What does the future hold for real-world data (RWD)? Looking back at the last couple of years and the accelerated adoption of RWD in research, evidence generation, HEOR and clinical trials, we can only guess the future use cases and how they will impact further healthcare innovation. Knowing how much data revolutionized other industry fields, […]
From Frozen to Dynamic: A Paradigm Shift in Real-World Data Utilization
Real-World Data (RWD) has been a cornerstone of the Life Sciences industry for decades, driving research, guiding clinical decisions, and informing policy. With recent FDA updates, the role of RWD continues to expand. However, traditional data extraction methods often result in “frozen” datasets, which pose significant challenges in a world that increasingly demands agility, updatability, […]
Unlocking Insights from RWD: An Interview with Dr. Or Shaked on Briya’s NLP-Driven Study for ISPOR Europe
As Briya prepares to present at ISPOR Europe 2024 (mark your calendars, this is happening on November 19th at 17:00), I sat down with Dr. Or Shaked, Medical Research Lead at Briya, who will be sharing insights from an innovative study on using Natural Language Processing (NLP) to uncover critical data in clinical research. It […]
Turning Hospitals Into Active Participants in Pharmaceutical Research
Today, data is one of the most valuable assets hospitals possess, with the global healthcare real-world data market estimated to be valued at $4 billion by 2030. Beyond improving patient care, this data can contribute to groundbreaking research, fuel advancements in medical science, and improve clinical outcomes. Healthcare data accounts for an estimated 30% of […]
Driving Clinical Innovation Through Real-World Data: Briya’s Strategic Collaboration with MSD
The future of healthcare is being reshaped by a wave of data-driven discovery, unleashing limitless potential for medical breakthroughs. With technology that enables unbounded access to vast, interconnected patient-level datasets, the healthcare industry is empowered to explore the complex fabric of human health in ways previously unimaginable. We’re now able to pull a needle from […]
5 Ways Real-Time Data is Revolutionizing Clinical Trials: Accelerating Research and Boosting ROI
Even though clinical trials are essential for gaining indispensable insights into treatments and obtaining regulatory approval for drug development, the administrative landscape of these trials proves to be challenging and difficult to navigate. With prevalent challenges such as patient recruitment and retention, increased complexity, and harsh regulatory hurdles, clinical trials often become extremely expensive and […]
New FDA Guidelines on Real-World Data: Implications for Healthcare Research and Innovation
The U.S. Food and Drug Administration (FDA) has recently released final guidance on the use of Real-World Data (RWD) in regulatory decision-making for drug and biological products. This landmark document, focusing on electronic health records (EHRs) and medical claims data, marks a significant step forward in the healthcare industry’s approach to drug development and approval […]
